Xingping Su
Impact in
-
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Pulmonary Hypertension Research and Treatments 1
-
- Liver physiology and pathology 2
- Co-authors
- Tinghong Ye (16 shared papers)Hongyao Liu (11 shared papers)Zhihao Liu (10 shared papers)Xiuli Wu (6 shared papers)Yue Lin (11 shared papers)Cailing Gan (10 shared papers)Yongxia Zhu (2 shared papers)Luoting Yu (5 shared papers)
- Journals
- European Journal of Medicinal Chemistry (7 papers)Journal of Medicinal Chemistry (3 papers)RSC Advances (2 papers)Biochemical Pharmacology (1 paper)Cell Proliferation (1 paper)
- Partner nations
- ChinaUnited KingdomJapan
In The Last Decade
Xingping Su
18 papers receiving 317 citations
Peers
Comparison fields: 5 of 55
- Molecular Biology 159
- Pulmonary and Respiratory Medicine 67
- Hepatology 16
- Organic Chemistry 36
- Oncology 22
Countries citing papers authored by Xingping Su
This map shows the geographic impact of Xingping Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingping Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingping Su more than expected).
Fields of papers citing papers by Xingping Su
This network shows the impact of papers produced by Xingping Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingping Su. The network helps show where Xingping Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Xingping Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 105 | |
| 2 | 2019 | 39 | |
| 3 | 2023 | 34 | |
| 4 | 2024 | 32 | |
| 5 | 2021 | 22 | |
| 6 | 2021 | 17 | |
| 7 | 2021 | 16 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2025 | 4 | |
| 15 | 2025 | 3 | |
| 16 | 2025 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2021 | 1 |
About Xingping Su
Xingping Su is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Molecular Biology, Organic Chemistry and Immunology and Allergy, having authored 18 papers that have together received 322 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Synthesis and biological activity (3 papers), Fibroblast Growth Factor Research (3 papers), Liver physiology and pathology (2 papers), Protein Degradation and Inhibitors (2 papers), Protease and Inhibitor Mechanisms (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper) and Pulmonary Hypertension Research and Treatments (1 paper). The work is most often cited by research in Molecular Biology (159 citations), Pulmonary and Respiratory Medicine (67 citations), Hepatology (16 citations), Organic Chemistry (36 citations) and Oncology (22 citations). Xingping Su has collaborated with scholars based in China, United Kingdom and Japan. Frequent co-authors include Tinghong Ye, Hongyao Liu, Zhihao Liu, Xiuli Wu, Yue Lin, Cailing Gan, Yongxia Zhu, Luoting Yu, Wei Wei and Yuting Xie. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, RSC Advances, Biochemical Pharmacology and Cell Proliferation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.